Does the pentavalent rotavirus vaccine prevent gastroenteritis and reduce health care resource utilization in the United States?
The pentavalent rotavirus vaccine is highly effective in preventing gastroenteritis and reducing healthcare utilization in routine clinical practice in the US.
In this first nationwide study evaluating VE under conditions of routine use, RV5 was highly effective in preventing RGE and AGE and in reducing health care resource utilization. Further research is needed to assess VE with an incomplete rotavirus vaccination regimen.
Wang et al. (Tue,) studied this question.